1. Home
  2. FORTY vs ADMA Comparison

FORTY vs ADMA Comparison

Compare FORTY & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FORTY

Formula Systems (1985) Ltd.

HOLD

Current Price

$106.50

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$8.75

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FORTY
ADMA
Founded
1985
2004
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
1998
2012

Fundamental Metrics

Financial Performance
Metric
FORTY
ADMA
Price
$106.50
$8.75
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$25.67
AVG Volume (30 Days)
414.0
3.3M
Earning Date
05-21-2026
05-06-2026
Dividend Yield
1.32%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.19
Revenue
N/A
$42,219,783.00
Revenue This Year
N/A
$27.46
Revenue Next Year
N/A
$22.11
P/E Ratio
$36.65
$45.89
Revenue Growth
N/A
43.85
52 Week Low
$106.50
$7.21
52 Week High
$190.56
$20.46

Technical Indicators

Market Signals
Indicator
FORTY
ADMA
Relative Strength Index (RSI) 33.61 52.30
Support Level $101.21 $7.38
Resistance Level $136.43 $8.90
Average True Range (ATR) 1.43 0.33
MACD -2.88 0.12
Stochastic Oscillator 0.00 67.24

Price Performance

Historical Comparison
FORTY
ADMA

About FORTY Formula Systems (1985) Ltd.

Formula Systems (1985) Ltd is an information technology company that is principally engaged through its directly and indirectly held investees in providing software consulting services, selling and marketing computer-based business solutions and hardware products from a wide range of domestic and international manufacturers, as well as developing proprietary software solutions. It delivers solutions in Israel and in numerous countries to customers with complex IT services needs. It designs and implements IT solutions and software systems that improve the productivity of customers' existing IT assets, enable them to effectively manage their operations and reduce their business risks in the face of changing business environments.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: